Peptide vaccines against hepatitis B virus: from animal model to human studies

This publication has 50 references indexed in Scilit:

• Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions.
  Journal of Clinical Investigation, 1998
• Positive role of macaque cytotoxic T lymphocytes during SIV infection: decrease of cellular viremia and increase of asymptomatic clinical period
  FEMS Immunology & Medical Microbiology, 1997
• Induction of cytotoxic T‐cell response by optimal‐length peptides does not require CD4⁺ T‐cell help
  Immunology, 1996
• Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides
  Vaccine, 1996
• Intracellular Inactivation of the Hepatitis B Virus by Cytotoxic T Lymphocytes
  Immunity, 1996
• Use of Intrinsic and Extrinsic Helper Epitopes for In Vivo Induction of Anti-Hepatitis C Virus Cytotoxic T Lymphocytes (CTL) with CTL Epitope Peptide Vaccines
  The Journal of Infectious Diseases, 1996
• Hepatitis B Virus Immunopathogenesis
  Annual Review of Immunology, 1995
• Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
  Journal of Clinical Investigation, 1995
• Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells
  Nature, 1990
• Induction of cytotoxic T lymphocytes by primary in vitro stimulation with peptides.
  The Journal of Experimental Medicine, 1988